Galderma Group (Switzerland) Performance
| GALD Stock | 154.20 0.40 0.26% |
Galderma Group has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.31, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Galderma Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Galderma Group is expected to be smaller as well. Galderma Group N right now retains a risk of 1.54%. Please check out Galderma Group coefficient of variation, jensen alpha, sortino ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if Galderma Group will be following its current trending patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Galderma Group N are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Galderma Group is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Forward Dividend Yield 0.001 | Payout Ratio | Forward Dividend Rate 0.15 | Dividend Date 2025-04-29 | Ex Dividend Date 2025-04-25 |
1 | Latham, Ropes Gray Advise as LOral Doubles Stake in Swiss Skincare Company Galderma - Law.com | 12/10/2025 |
2 | Is Galderma Group AGs Recent Stock Performance Influenced By Its Financials In Any Way - Yahoo Finance | 01/05/2026 |
3 | Galderma appoints Luigi La Corte as new CFO effective May 2026 - Investing.com India | 02/16/2026 |
| Begin Period Cash Flow | 368 M | |
| Total Cashflows From Investing Activities | -287.1 M | |
| Free Cash Flow | 213 M |
Galderma |
Galderma Group Relative Risk vs. Return Landscape
If you would invest 14,970 in Galderma Group N on November 24, 2025 and sell it today you would earn a total of 450.00 from holding Galderma Group N or generate 3.01% return on investment over 90 days. Galderma Group N is generating 0.061% of daily returns and assumes 1.5361% volatility on return distribution over the 90 days horizon. Simply put, 13% of stocks are less volatile than Galderma, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Galderma Group Target Price Odds to finish over Current Price
The tendency of Galderma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 154.20 | 90 days | 154.20 | about 59.46 |
Based on a normal probability distribution, the odds of Galderma Group to move above the current price in 90 days from now is about 59.46 (This Galderma Group N probability density function shows the probability of Galderma Stock to fall within a particular range of prices over 90 days) .
Galderma Group Price Density |
| Price |
Predictive Modules for Galderma Group
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Galderma Group N. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Galderma Group Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Galderma Group is not an exception. The market had few large corrections towards the Galderma Group's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Galderma Group N, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Galderma Group within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 7.14 | |
Ir | Information ratio | -0.02 |
Galderma Group Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Galderma Group for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Galderma Group N can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| About 36.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Galderma appoints Luigi La Corte as new CFO effective May 2026 - Investing.com India |
Galderma Group Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Galderma Stock often depends not only on the future outlook of the current and potential Galderma Group's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Galderma Group's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 237.6 M | |
| Cash And Short Term Investments | 457 M |
Galderma Group Fundamentals Growth
Galderma Stock prices reflect investors' perceptions of the future prospects and financial health of Galderma Group, and Galderma Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Galderma Stock performance.
| Return On Equity | 0.0492 | ||||
| Return On Asset | 0.0367 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 37.25 B | ||||
| Shares Outstanding | 234.82 M | ||||
| Price To Book | 5.95 X | ||||
| Price To Sales | 7.81 X | ||||
| Revenue | 4.44 B | ||||
| Gross Profit | 3.25 B | ||||
| EBITDA | 959 M | ||||
| Net Income | 231 M | ||||
| Cash And Equivalents | 175 M | ||||
| Total Debt | 2.76 B | ||||
| Book Value Per Share | 25.31 X | ||||
| Cash Flow From Operations | 429.77 M | ||||
| Earnings Per Share | 1.22 X | ||||
| Market Capitalization | 36.61 B | ||||
| Total Asset | 12.62 B | ||||
| Retained Earnings | 5.68 B | ||||
About Galderma Group Performance
Evaluating Galderma Group's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Galderma Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Galderma Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 124.84 | 131.43 | |
| Return On Tangible Assets | 0.08 | 0.08 | |
| Return On Capital Employed | 0.05 | 0.04 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.03 | 0.03 |
Things to note about Galderma Group N performance evaluation
Checking the ongoing alerts about Galderma Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Galderma Group N help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 36.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Galderma appoints Luigi La Corte as new CFO effective May 2026 - Investing.com India |
- Analyzing Galderma Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Galderma Group's stock is overvalued or undervalued compared to its peers.
- Examining Galderma Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Galderma Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Galderma Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Galderma Group's stock. These opinions can provide insight into Galderma Group's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Galderma Stock Analysis
When running Galderma Group's price analysis, check to measure Galderma Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galderma Group is operating at the current time. Most of Galderma Group's value examination focuses on studying past and present price action to predict the probability of Galderma Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galderma Group's price. Additionally, you may evaluate how the addition of Galderma Group to your portfolios can decrease your overall portfolio volatility.